USPTO serial 79317618
CPO
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 16, 2023
- Examiner
- CORNWELL, ANDREA B
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with CPO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Pharmako Biotechnologies Pty Limited
AU
Other trademarks owned by Pharmako Biotechnologies Pty Limited
Pharmako Biotechnologies Pty Limited
AU
Other trademarks owned by Pharmako Biotechnologies Pty Limited
Pharmako Biotechnologies Pty Limited
AU
Other trademarks owned by Pharmako Biotechnologies Pty Limited
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jennifer A. Visintine
Jennifer A. Visintine Thompson Coburn LLPOne US Bank PlazaSt. Louis, MO 63101UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medicines in tablet form for the treatment of nutritional and vitamin deficiencies; medicated preparations in the form of powders, namely, drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; veterinary preparations in the form of powder, namely, drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of veterinary pharmaceuticals; veterinary preparations, namely, dietary and nutritional supplements for veterinary use; medical preparations, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; medicated food additives being pharmaceutical products that facilitate or increase the absorption of vitamins and minerals; medicated supplements for foodstuffs for animals; medicated supplements for foodstuffs for human consumption for medical purposes; medicated skin care preparations; medicated preparations for use as supplements for food for medical purposes; powders for skin care for medical use; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; medicinal oils containing vitamins and minerals; oils adapted for pharmaceutical purposes, namely, for the increasing the bioavailability and absorption of active ingredients in foodstuffs and medicines; oils for use in medicine, namely, medicated oils containing vitamins and minerals; dietary supplements; pharmaceutical preparations, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; dietetic foods adapted for medical purposes; dietetic substances namely foods, beverages and supplements adapted for medical use; dietetic substances, namely foods, beverages and supplements for veterinary use; dietary supplements; dietary supplements for animals; nutritional meal replacements, namely beverages and supplements adapted for medical use; nutritional preparations for medical use, namely, medications used for the delivery and absorption of nutrients; nutritional supplements; medicinal healthcare products, namely, dietary supplements with medicinal properties that increase the bioavailability and absorption of active ingredients in foodstuffs and medicines; chemical products for use in medical or veterinary biotechnology, namely, chemical preparations for increasing bioavailability and absorption of active ingredients in foodstuffs and medicines; biotechnological preparations for medical use, namely, mixed biological preparations for the prevention and treatment of nutritional deficiencies; chemical products for medical use, namely, chemical reagents for medical purposes; dietary supplements with a cosmetic effect; medicated skin creams for personal care; medicated preparations for the regeneration of the skin; medicated preparations for the treatment of the skin; medicated preparations for use in the bath; medicated creams for the face | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Pharmako Biotechnologies Pty Limited
- Other trademarks owned by Pharmako Biotechnologies Pty Limited
- Other trademarks owned by Pharmako Biotechnologies Pty Limited
- Other trademarks in Class 005
- Similar marks named CPO
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 12, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 17, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 17, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Aug 16, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 16, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| May 16, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 28, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 28, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 27, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Feb 8, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 8, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Feb 8, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 6, 2023 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jan 26, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 18, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 18, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 18, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 18, 2023 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jan 18, 2023 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Sep 17, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 28, 2022 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jul 28, 2022 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 28, 2022 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 14, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 13, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 13, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 8, 2022 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jul 8, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 8, 2022 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jul 8, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 8, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 8, 2022 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jan 30, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 13, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 13, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 22, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 21, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 17, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 24, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 18, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 16, 2021 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Aug 12, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |